• Chenodeoxycholic Acid in FXR Research

  2026-08-12

  Chenodeoxycholic Acid enables controlled FXR activation for cholesterol metabolism research, bile acid metabolism, and mechanistic kidney-injury workflows. This guide translates the FXR–KLF11 discovery into practical dosing, assay-design, and troubleshooting decisions.

• AICAR Phosphate: From AMPK to Translational Design

  2026-08-11

  A mechanistic and translational perspective on AICAR phosphate (Acadesine), connecting AMPK-driven apoptosis in B-CLL research with emerging evidence on hypoxia, oxidative stress, macrophage polarization, and choroid plexus barrier dysfunction.

• Phenothiazines Boost Macrophage Antibacterial Defense

  2026-08-10

  The 2025 Frontiers in Immunology study identifies phenothiazines as host-directed antibacterial leads that strengthen macrophage activity through reactive oxygen species, autophagy, and lysosomal responses. Its perphenazine experiments connect these cellular mechanisms with reduced Salmonella Typhimurium-associated tissue injury in vivo, while also highlighting the need for target validation and translational safety studies.

• GSK J4 HCl: JMJD3 Inhibitor Workflow Guide

  2026-08-09

  Build reproducible chromatin and inflammatory assays with GSK J4 HCl, a cell-permeable JMJD3 inhibitor that connects H3K27 demethylation to transcriptional output. This guide translates decidual CXCL10 research into practical controls, dosing strategies, and troubleshooting steps while distinguishing established evidence from proposed applications.

• In Vitro Drug Response: Beyond Viability

  2026-08-08

  Hannah Schwartz’s dissertation shows that relative viability and fractional viability capture different components of an anticancer response: proliferative arrest and cell killing. Its central contribution is a more discriminating in vitro framework that accounts for response magnitude, composition, and timing, helping researchers interpret checkpoint-targeting and DNA damage response experiments more accurately.

• DiscoveryProbe Bioactive Compound Library Plus Workflow

  2026-08-07

  Turn a 5,072-compound collection into a disciplined ligand-discovery and pathway-validation workflow. This guide combines thermal shift assay triage, orthogonal binding confirmation, and cell-based follow-up for protease inhibition, apoptosis, cancer research, and signaling studies.

• Perphenazine: Bridging Neuropharmacology and Host Immunity

  2026-08-07

  This thought-leadership article explores how Perphenazine, a dopamine D2 receptor antagonist with a robust multi-receptor profile, is redefining translational research. By blending mechanistic insight with strategic guidance, the piece delves into Perphenazine’s roles in neuropharmacology, mitochondria-mediated cell death, opioid tolerance suppression, and—importantly—host-directed antibacterial defense via macrophage activation. Drawing on recent evidence, it outlines protocol parameters, competitive context, and a forward-looking perspective for researchers seeking to advance both neuroscience and infectious disease therapeutics.

• Berbamine Hydrochloride in NF-κB Signaling and Cancer Models

  2026-08-06

  Berbamine hydrochloride is redefining cancer research by acting as a potent NF-κB activity inhibitor and modulator of ferroptosis resistance. This article details advanced workflows, troubleshooting strategies, and protocol enhancements for integrating this compound into translational studies targeting leukemia and hepatocellular carcinoma.

• PDE4B Inhibition Restores Endothelial Function via AMPK/Sirt

  2026-08-06

  This study demonstrates that PDE4B abrogation counters angiotensin II-induced endothelial dysfunction in human endothelial cells by activating the AMPK/Sirt1/Nrf2/ARE signaling pathway. The work clarifies the mechanistic link between PDE4B and metabolic stress responses, highlighting new avenues for hypertension research and therapeutic targeting.

• Partial BACE1 Inhibition Reduces Amyloid Beta Without Synapt

  2026-08-05

  Satir et al. (2020) demonstrate that moderate inhibition of the BACE1 enzyme—reducing amyloid beta (Aβ) production by up to 50%—does not impair synaptic transmission in primary cortical neurons. This finding refines therapeutic strategies for Alzheimer's disease, highlighting the importance of dosing in BACE inhibitor research.

• Data-Driven Design of Small-Molecule Libraries for Kinome Re

  2026-08-05

  Moret et al. (2019) advance the field of small-molecule library design by introducing robust cheminformatics tools for evaluating and assembling optimized compound collections. Their approach, focusing on binding selectivity and target coverage, offers a significant improvement in the ability to design focused libraries for kinase and mechanism-of-action studies, with practical implications for drug discovery and translational research.

• Streptavidin-FITC: Advanced Biotin Detection & Workflow Tips

  2026-08-04

  Streptavidin-FITC from APExBIO enables ultra-sensitive, quantitative detection of biotinylated targets in immunofluorescence, flow cytometry, and in situ hybridization. This guide breaks down experimental workflows, troubleshooting tactics, and novel insights from recent microbiome–cancer adhesion research.

• Transcobalamin 1 Drives Psoriasis via DNA Hypomethylation an

  2026-08-04

  This study identifies transcobalamin 1 (TCN1) as a keratinocyte-derived autoantigen reactivated by DNA hypomethylation in psoriasis. Through integrated multi-omics and functional immunology, the findings clarify how TCN1 amplifies TH17 cell/IL-17 immunity and keratinocyte hyperproliferation, advancing understanding of autoimmune mechanisms and therapeutic targeting in psoriasis.

• Pertussis Toxin: Beyond Immune Modulation—New Horizons in TH

  2026-08-03

  Explore the advanced roles of Pertussis toxin, an AB5-type protein exotoxin, in dissecting TH17 cell differentiation and autoimmune mechanisms. This article delivers unique insights linking immune response modulation to practical assay innovation, distinct from workflow-focused content.

• Angiotensin (1-7): Applied Protocols and PI3K/AKT Modulation

  2026-08-03

  Angiotensin (1-7) (Asp-Arg-Val-Tyr-Ile-His-Pro) offers researchers a unique tool for anti-fibrotic and anti-inflammatory studies, with robust solubility and purity for reliable experimental outcomes. This article delivers actionable workflows and troubleshooting strategies, while spotlighting new mechanistic insights from recent peptide–receptor interaction research.

447 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page